PharmacoEconomics

The Use of Meta-Analysis in Cost-Effectiveness Analysis: Issues and Recommendations
pp. 1-8(8)
Authors: Saint S.; Veenstra D.L.; Sullivan S.D.

Willingness to Pay as a Measure of Health Benefits
pp. 9-18(10)
Authors: Bala M.V.; Mauskopf J.A.; Wood L.L.

Evaluating Health-Related Quality-of-Life Outcomes in Patients with Congestive Heart Failure: A Review of Recent Randomised Controlled Trials
pp. 19-46(28)
Authors: Leidy N.K.; Rentz A.M.; Zyczynski T.M.

Pharmacoeconomics of Lipid-Lowering Agents for Primary and Secondary Prevention of Coronary Artery Disease
pp. 47-74(28)
Authors: Hay J.W.; Yu W.M.; Ashraf T.

Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain
pp. 75-83(9)
Authors: Jiménez F.J.; Guallar-Castillón P.; Terrés C.R.; Guallar E.

Cost Analysis of 2 Empiric Antibacterial Regimens Containing Glycopeptides for the Treatment of Febrile Neutropenia in Patients with Acute Leukaemia
pp. 85-95(11)
Authors: Bucaneve G.; Menichetti F.; Favero A.D.

Economic Evaluation of Antibacterials in the Treatment of Acute Sinusitis
pp. 97-113(17)
Authors: Laurier C.; Lachaine J.; Ducharme M.